Monte Rosa Therapeutics
GLUE
GLUE
56 hedge funds and large institutions have $759M invested in Monte Rosa Therapeutics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
56
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$58.1M | |
| 2 | +$20.5M | |
| 3 | +$11.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.01M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.36M |
Top Sellers
| 1 | -$7.95M | |
| 2 | -$7.95M | |
| 3 | -$5.57M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$3.4M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.94M |